Skip to main content
Premium Trial:

Request an Annual Quote

Seegene Launches US Subsidiary

NEW YORK (GenomeWeb) – Seegene today announced it has established Seegene Technologies, a new US subsidiary based in Concord, Calif.

The South Korean firm said it plans to enhance its sales in the US by directly managing existing clients and gaining new ones. Seegene will also pursue several US Food and Drug Administration submissions of reagents for multiplexed tests to detect respiratory and gastrointestinal infections.

Seegene is looking to develop original design manufacturing partnerships with in vitro diagnostics firms and plans to establish a cGMP facility and a US manufacturing and supply system by 2017, the firm said in a statement.

Seegene CEO Jong-Yoon Chun said that a US subsidiary was an important step in growing the firm's global market presence.

In February, Seegene obtained its first FDA 510(k) market clearance for its TOCE-based assay to detect herpes simplex viruses 1 and 2.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.